NEUROLOGY
KEY OPINION LEADERS
BETTER LIFE'S PRODUCT LAUNCH BLUEPRINT
To identify and utilize relevant datasets to create metrics and develop a methodology for identifying and profiling Key Opinion Leaders in Neurology for Product Launch
AGENDA
OBJECTIVE
Strategically identify US neurology KOLs to champion Better Life's product launch, leveraging critical datasets to pinpoint influencers
METHODOLOGY
A robust analysis integrates clinical, research, leadership, and financial data to profile key neurology KOLs, assessing their impact and network
IMPACT
Engaging KOLs is vital for product adoption and market success, laying the groundwork for Better Life's entry and growth in the neurology sector
EXECUTIVE SUMMARY
Key Opinion Leaders (KOLs) are esteemed experts in their medical fields whose knowledge, research, and opinions significantly influence peers and industry trends
KEY OPINION LEADERS
They are often sought after for their expertise in guiding treatment practices and product endorsements
Clinical Trial Advocacy
KOLs ensure clinical trials are scientifically sound and relevant which boosts trial credibility and encourages wider participation
THEIR IMPACT
Product Launch and Adoption
KOLs endorse new products, speeding up market acceptance and their educational efforts help healthcare providers embrace innovations
Influence on Guidelines and Policies
KOLs shape treatment guidelines and healthcare policies and their recommendations impact therapeutic approaches and improve patient care
Insights and Expertise
KOL engagement provides access to valuable knowledge and experience through which companies gain insights into patient needs and healthcare gaps
THEIR VALUE
Strategic Influence
KOL input shapes development, marketing, and educational strategies and their expertise guides product positioning and messaging effectively
Trust and Guidance
KOL endorsement enhances credibility and assists in navigating complex healthcare landscapes, aiding effective communication of product value
WHO IS OUR CLIENT AND WHAT IS THE TASK AT HAND?
Before we dive deep, let's try to answer this question:
The mission is to harness data-driven insights to identify and engage neurology KOLs, amplifying product launch success and market penetration
Better Life is poised to disrupt the US neurology pharmaceutical market with an innovative product, amidst a landscape ripe for advanced therapeutic solutions
HOW DO WE CHOOSE OUR KOL ?
S
We build advanced metrics from our data through which we select the most impactful KOLs for our current product
IDENTIFICATION OF KEY METRICS
WHICH SOURCES?
SOURCE 1
openpaymentsdata.cms.gov/
SOURCE 2
reporter.nih.gov/
health.usnews.com/best-hospitals/rankings/neurology-and-neurosurgery
1'st Priority
2'nd Priority
Last Priority
https://clinicaltrials.gov/
We used the data above this line.
SOURCE 3
SOURCE 4
SOURCE 5
WHY THESE SOURCES?
OPENPAYMENTSDATA.CMS.GOV/
The Open Payments database enhances healthcare transparency by showcasing financial relationships between healthcare providers and the industry. We took a subset of the data (2022).
REPORTER.NIH.GOV/
HEALTH.USNEWS.COM/BEST-HOSPITALS/RANKINGS/NEUROLOGY-AND-NEUROSURGERY
NIH RePORTER consolidates NIH-funded research projects, outcomes, and resulting publications and patents, supporting transparency, informed decision-making, and public accountability in research funding. We took a subset of 2020 - 2024 to consider years around the date 2022.
U.S. News offers rankings and insights on top hospitals for neurology and neurosurgery, aiding in informed care choices for complex neurological issues through data and expert opinions. We found out the institutions and its rank, and attached to each profile.
TOTAL PAYMENTS
COUNT OF PUBLICATIONS
PROJECTS
COUNT
RANK OF ORGANISATION
RELATIVE CITATION RATE
CLINICAL TRIALS COUNT
METRICS IDENTIFIED
RELVANCE SCORE
DEGREE CENTRALITY
HOW TO UTILIZE THE METRICS ?
This is a decision-making tool that decomposes complex problems into a hierarchy of simpler elements, evaluated through pairwise comparisons. It combines quantitative metrics and subjective judgments to assign weights to each element, enabling informed and consistent decision-making
ANALYTIC HIERARCHY PROCESS
Parameters | Total Payments | Clinical Trials | Publications | Relative Citation Rate | Organisational Rank | Projects | Relevance Score | Degree Centrality |
Total Payments | 1 | 3 | 2 | 2 | 4 | 3 | 2 | 3 |
Clinical Trials | 1/3 | 1 | 4 | 5 | 2 | 4 | 5 | 4 |
Publications | 1/2 | 1/4 | 1 | 6 | 1/3 | 2 | 6 | 5 |
Relative Citation Rate | 1/2 | 1/5 | 1/6 | 1 | 1/4 | 1/3 | 1/2 | 1/3 |
Organisational Rank | 1/4 | 1/2 | 3 | 4 | 1 | 1/2 | 3 | 2 |
Projects | 1/3 | 1/4 | 1/2 | 3 | 2 | 1 | 4 | 3 |
Relevance Score | 1/2 | 1/5 | 1/6 | 2 | 1/3 | 1/4 | 1 | 1/2 |
Degree Centrality | 1/3 | 1/4 | 1/5 | 3 | 1/2 | 1/3 | 2 | 1 |
This matrix uses fractional values for the inverse comparisons for simplicity, though typically the exact reciprocal would be used (e.g., if A is 4 times as important as B, then B is 1/4 as important as A).
The diagonal is always 1, as each metric is equally important to itself.
COMPARISON MATRIX
COMPARISON MATRIX
Explanation of Assumptions:
This matrix is an illustrative example. In practice, the specific weights and the importance of each parameter should be determined through a collaborative process involving domain experts, using a systematic approach like the Analytic Hierarchy Process (AHP) to reach a consensus.
RELEVANCE SCORE
The Relevance Score is a tailored metric designed to personalize researcher recommendations for our product by evaluating the congruence of their past work with relevant fields
We took the example of a new drug in the market, Lecanemab for Alzheimer's treatment to build this
It operates on a 0 to 1 scale, ensuring precise alignment between a researcher's expertise and the specific needs of our project
BENEFIT
This facilitates targeted engagements, enhancing the efficacy and impact of collaborations tailored to our product's development and research objectives
DEGREE CENTRALITY
Degree Centrality quantifies a researcher's direct connections in their professional network, indicating their collaborative reach and centrality in the research community. It highlights:
Incorporating Degree Centrality compliments traditional academic metrics and underscores the significance of networking in research advancement
DEGREE CENTRALITY
Incorporating Degree Centrality compliments traditional academic metrics and underscores the significance of networking in research advancement
*Created using the Network X Library in Python
Summation Across Columns: For each column in the pairwise comparison matrix, we add the values. This reflects the combined influence that each criterion has when compared against all others.
Normalization of Elements: Each element in the matrix is divided by the sum of its respective column. This adjustment ensured that the sum of each column equaled 1, standardizing the scales for comparability.
Weight Calculation: For each row in the normalized matrix, we calculated the average of its values. These averages represented the relative weights or priorities of the criteria, indicating their importance in the decision-making context.
Total Payments | 0.172 |
Clinical Trials Count | 0.166 |
Publications Count | 0.110 |
Relative Citation Rate | 0.089 |
Organisational Rank | 0.098 |
Projects | 0.088 |
Relevance Score | 0.046 |
Degree Centrality | 0.232 |
NORMALIZED
WEIGHTS
Comprehensive approach and Business Rules to identify KOLs
ANALYTICAL METHODOLOGY
IMPACT
SCORE
The "Impact Score" distills a researcher's professional achievements into a single, comprehensive metric, reflecting their influence across academia and industry. By blending contributions in publications, clinical trials, and leadership with their role in collaborative projects and the relevance of their work, this score offers a nuanced view of a researcher's standing and potential in their field
We wil be using the Impact Score to find the KOL with the highest Impact
IMPACT SCORE CALCULATION
STANDARDIZATION
WEIGHTED SUM CALCULATION
WEIGHT ASSIGNMENT
INVERSION FOR RANK
ROUNDING
IMPACT SCORE CALCULATION
STANDARDIZATION
WEIGHTED SUM CALCULATION
WEIGHT ASSIGNMENT
INVERSION FOR RANK
ROUNDING
Invert rank values where necessary, so that a lower rank translates to a higher value after scaling
Use a MinMaxScaler to scale the values of each metric to a 0 to 1 range, ensuring comparability across different scales
Assign weights to each metric based on their relative importance in determining a researcher's impact, as established through methods like the Analytic Hierarchy Process (AHP)
Multiply the normalized values by their corresponding weights and sum these products for each researcher to calculate their overall "Impact Score"
Round the final "Impact Score" to a suitable number of decimal places, maintaining precision and readability.
RELEVANCE SCORE
BINNING
The "Relevance Score Classification" categorizes the alignment of a researcher's previous work with specific projects or areas of interest into three distinct tiers:
BENEFIT
This classification provides a quick, intuitive understanding of how closely a researcher's background matches the specific needs or goals of a project, aiding in more informed decision-making.
Academic Data Collection: Gather detailed academic data for each candidate, including publications, citations, and affiliations
Calculation of Relevance Score: Assess the alignment of candidates' previous work with the current project
Degree Centrality Analysis: Evaluate candidates' networks to determine their Degree Centrality, reflecting their collaborative reach and influence within professional circles
Relevance of Non-Academic Indicators: Acknowledge the significance of Relevance Score and Degree Centrality as indicators that extend beyond traditional academic metrics
OUR PROCESS FLOW
STEP 1
DATA COLLECTION AND METRIC CALCULATION
Clearly outline the goals and necessary qualifications for the role or project, ensuring the selection criteria align with the desired outcomes
OUR PROCESS FLOW
STEP 2
DEFINE SELECTION OBJECTIVES
Establish a minimum Impact Score for candidate consideration, emphasizing its role as a primary indicator of overall contributions and influence
STEP 3
SET IMPACT SCORE THRESHOLD
Initially rank candidates based on their Impact Scores from highest to lowest, using this as the foundational layer for the selection process
OUR PROCESS FLOW
STEP 4
RANK CANDIDATES BY IMPACT SCORE
OUR PROCESS FLOW
Relevance Score Classification: Use the High, Medium, or Low relevance classification to identify candidates with expertise closely aligned with project needs
Degree Centrality: Consider candidates' Degree Centrality to gauge their collaborative potential and network influence
STEP 5
Incorporate Additional Indicators
OUR PROCESS FLOW
Review top candidates, particularly those with high Impact Scores, focusing on individual score components and the added context from Degree Centrality and Relevance Score Classification
STEP 6
CONDUCT CANDIDATE EVALUATION
OUR PROCESS FLOW
Make balanced decisions by weighing the comprehensive evaluations, where the Impact Score indicates overall merit, supplemented by nuanced insights from additional indicators
Ensure selections are strategically aligned with project goals and organizational objectives
STEP 7
FINALIZE SELECTION
SEGMENTS
High Impact Leaders
Candidates with exceptionally high Impact Scores, indicating significant contributions and influence in their field. They are often thought leaders or pioneers
Emerging Influencers
Those with moderate to high Impact Scores, showing promise and upward trajectory in their contributions and recognition
Specialized Contributors
Individuals with lower overall Impact Scores but high scores in specific components, indicating specialized expertise or contributions.
ARCHETYPES
Central Connectors
High Degree Centrality candidates, pivotal in networks due to their extensive collaborations. They are ideal for roles requiring broad interdisciplinary connections
Niche Experts High Relevance Score in specific areas with moderate Degree Centrality, indicating deep, focused expertise relevant to particular projects or niches
Influential Innovators
High scores in both Impact and Degree Centrality, marking them as influential figures who drive innovation and collaboration
WEBSITE
Discover Better life
Come visit us to understand more about our product offerings.
Use our Gen AI chatbot to learn more about how we do it!
Visit: https://betterlifekol.online/
WEBSITE
Discover Better life
Come visit us to understand more about our product offerings.
Visit: https://betterlifekol.online/
Use our Gen AI chatbot to learn more about how we do it!
WEBSITE
Discover Better life
Come visit us to understand more about our product offerings.
Visit: https://betterlifekol.online/
Use our Gen AI chatbot to learn more about how we do it!
WEBSITE
Discover Better life
Come visit us to understand more about our product offerings.
Visit: https://betterlifekol.online/
Use our Gen AI chatbot to learn more about how we do it!
WEBSITE
Discover Better life
Come visit us to understand more about our product offerings.
Visit: https://betterlifekol.online/
Use our Gen AI chatbot to learn more about how we do it!
Sign up
Type Here
Jiara Martins
Learn More
Give us details about your product
NAME
NEW PRODUCT
Get in touch with the KOL providers to promote
THE LONG WAIT IS OVER
Recommendations
Using our proprietary models
Extracts information from trustworthy sources
Builds on qualitative and quantitative metrics
Gives personalized recommendations using AI
State of the Art Models
WIREFRAMING
Who are the best fit ?
KOL PROFILING
NET PAYMENTS
$234,047
PROJECTS
15
publications
133
RELATIVE CITATION RATE
5.58
NPI: 1740398494
Location: ATLANTA, GA
Degree centrality 0.085
Relvance score
0.4
Impact score
0.425
LEVEY, ALLAN I
Allan Levey, MD, PhD, is a professor in the Department of Neurology at Emory University's School of Medicine, as well as the director of Emory's Alzheimer's Disease Research Center. He has secondary faculty appointments in the Departments of Pharmacology, Psychiatry and Behavioral Sciences.
Segment: Emerging Influencers Archetype: Degree Centrality
NET PAYMENTS
$7,527,875
PROJECTS
9
publications
227
RELATIVE CITATION RATE
4.9
NPI: 1649296872
Location: SAINT LOUIS, MO
Relvance score
0.2
Impact score
0.362
BATEMAN, RANDALL J
Randall J. Bateman, MD, is the Charles F. and Joanne Knight Distinguished Professor of Neurology at Washington University School of Medicine, director of the Dominantly Inherited Alzheimer Network (DIAN) and director of the DIAN Trials Unit (DIAN-TU).
Segment: Specialized Contributor Archetype: Niche Expert
Quality Checks to ensure legitimacy
VALIDATION AND ACCURACY ASSESSMENTS
Verify the presence of all required fields: researcher names, affiliations, publication details, and project information done via merging datasets.
Ensure comprehensive coverage of publications and projects across relevant research domains and timeframes. (We took years around 2022).
Cross-reference researcher profiles and publications across multiple databases to identify discrepancies.
Plan for periodic updates to the dataset to capture dynamic changes in research networks.
Secure necessary permissions for using proprietary or sensitive data. (We scraped only public data).
WHAT QC CHECKS DO WE RECOMMEND?
WHAT ABOUT THE ACCURACY?
VERITY?
Verifying the KOL’s selected via platforms like Linkedin and Google scholar.
Compare the identified KOLs with authoritative rankings and databases in the field to check for alignment.
Examine the citation impact of KOLs’ publications to assess their influence in the research community. We have done this manually by extensively going through the work of the KOL’s online.
Looking at the results and the model we created from a business perspective to bring value to companies/clients looking for KOL’s.
The details mentioned here may have errors and need slight improvements
For any changes kindly email agarw402@purdue.edu
kurada@purdue.edu
streasu@purdue.edu
REMEMBER
THANK YOU!
Use the QR code to explore our website and chatbot!
SOHAM
PAWAN
SIDDHANT